HCFA Insulin Pump Coverage Decision Estimates Annual Cost At $3,329
This article was originally published in The Gray Sheet
Executive Summary
The annual cost of insulin therapy administered through a subcutaneous infusion pump is $3,329, the Health Care Financing Administration estimates in a Medicare national coverage decision for the devices in Type I diabetes announced Sept. 24. An effective date will be specified in an upcoming instruction to carriers.
You may also be interested in...
Glucose Monitor Useful In Identifying Asymptomatic Diabetics, MiniMed Says
MiniMed's planned introduction of a consumer version of its continuous home glucose monitor (CGMS) in 2001 is unlikely to result in the phasing-out the professional version introduced in July, given the recent physician debate about what separates a diabetic patient from a "normal" patient.
Glucose Monitor Useful In Identifying Asymptomatic Diabetics, MiniMed Says
MiniMed's planned introduction of a consumer version of its continuous home glucose monitor (CGMS) in 2001 is unlikely to result in the phasing-out the professional version introduced in July, given the recent physician debate about what separates a diabetic patient from a "normal" patient.
Insulin infusion pumps
Estimated annual cost of therapy for Type I diabetes is about $3,330, according to a national coverage decision announced by the Health Care Financing Administration Sept. 24. The agency has yet to make a final payment decision covering the treatment modality, as was incorrectly reported Sept. 27 in "The Gray Sheet" (1p. 12)